Yang QuanJun

13PUBLICATIONS
29CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markersMedical biochemistry - amino acids and metabolites
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 25, 2026
Targeting the CD47-SIRPĪ± phagocytic checkpoint in cancer: Biology, translational opportunities, and next-generation therapeutic strategies.

|May 07, 2026
Fisetin Promotes Autophagy in Osteosarcoma by Activating the ROS/FOXO3 Axis via Oxidative Stress.

|Jan 19, 2026
A charge-reversal prodrug activated by tumor-acidity for selective cancer chemotherapy.

Bing Liu, Guanchun Wang, Quanjun Yang

|Sep 08, 2025
Arginine Metabolism in Cancer Biology and Immunotherapy.

DingYuan Bai, YuXuan Zhou, LingJie Jing

|Jun 10, 2024
The Pan-Cancer Analysis Uncovers the Prognostic and Immunotherapeutic Significance of CD19 as an Immune Marker in Tumor.

Lanyi Wei, Jingjing Meng, Danfeng Xiang

|Dec 27, 2023
Bckdk-Mediated Branch Chain Amino Acid Metabolism Reprogramming Contributes to Muscle Atrophy during Cancer Cachexia.

Li Chen, Hong Zhang, Mengyi Chi

Pageof 3

Frequent Collaborators

4 joint publications

Cheng Guo

1 joint publications

Paul Renauer

1 joint publications

Jonathan J Park

1 joint publications

Meizhu Bai